Elliott; Jason Matthew
Patent Applications and Registrations
Patent applications and USPTO patent grants for Elliott; Jason Matthew.The latest application filed is for "heterobicyclic carboxamides as inhibitors for kinases".
- Elliott; Jason Matthew - Cambridge MA US
- Elliott; Jason Matthew - Felsted GB
- Elliott; Jason Matthew - Harlow GB
- Elliott; Jason Matthew - Knockholt GB2
| Patent | Date |
|---|---|
| Heterobicyclic carboxamides as inhibitors for kinases Grant 8,541,432 - Artman, III , et al. September 24, 2 | 2013-09-24 |
| Heterobicyclic carboxamides as inhibitors for kinases Grant 8,501,756 - Artman, III , et al. August 6, 2 | 2013-08-06 |
| Heterobicyclic carboxamides as inhibitors for kinases Grant 8,492,393 - Artman, III , et al. July 23, 2 | 2013-07-23 |
| Heterobicyclic carboxamides as inhibitors for kinases Grant 8,486,954 - Artman, III , et al. July 16, 2 | 2013-07-16 |
| Heterobicyclic carboxamides as inhibitors for kinases Grant 8,431,584 - Artman, III , et al. April 30, 2 | 2013-04-30 |
| Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130012529 - ARTMAN, III; Gerald David ; et al. | 2013-01-10 |
| Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130005750 - ARTMAN, III; Gerald David ; et al. | 2013-01-03 |
| Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130005751 - ARTMAN, III; Gerald David ; et al. | 2013-01-03 |
| Heterobicyclic Carboxamides As Inhibitors For Kinases App 20130005753 - ARTMAN, III; Gerald David ; et al. | 2013-01-03 |
| Heterobicyclic Carboxamides As Inhibitors For Kinases App 20120245187 - ARTMANN, III; Gerald David ; et al. | 2012-09-27 |
| Heterobicyclic carboxamides as inhibitors for kinases Grant 8,242,125 - Artman, III , et al. August 14, 2 | 2012-08-14 |
| Heterobicyclic Carboxamides as inhibitors for kinases App 20100168082 - Artmann, III; Gerald David ; et al. | 2010-07-01 |
| Quinoline derivatives as neurokinin receptor antagonists App 20090054440 - Carling; William Robert ; et al. | 2009-02-26 |
| Tetrahydropyran compounds as tachykinin antagonists Grant 7,393,858 - Dirat , et al. July 1, 2 | 2008-07-01 |
| Quinoline Derivatives as Neurokinin Receptor Antagonists App 20080096885 - Carling; William Robert ; et al. | 2008-04-24 |
| Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents Grant 7,253,205 - Castro Pineiro , et al. August 7, 2 | 2007-08-07 |
| Sulphones for inhibition of gamma secretase Grant 7,161,006 - Crawforth , et al. January 9, 2 | 2007-01-09 |
| Cyclohexane derivatives and their use as therapeutic agents Grant 7,105,507 - Castro Pineiro , et al. September 12, 2 | 2006-09-12 |
| Tetrahydropyran compounds as tachykinin antagonists App 20060172999 - Dirat; Olivier ; et al. | 2006-08-03 |
| Novel sulphones for inhibition of gamma secretase App 20050261276 - Crawforth, James Michael ; et al. | 2005-11-24 |
| Tetrahydropyran derivatives and their use as therapeutic agents App 20050261285 - Dirat, Olivier ; et al. | 2005-11-24 |
| Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents App 20040171642 - Pineiro, Jose Luis Castro ; et al. | 2004-09-02 |
| Cyclohexane derivatives and their use as therapeutic agents App 20030236250 - Castro Pineiro, Jose Luis ; et al. | 2003-12-25 |
| Cyclohexyl derivatives and their use as therapeutic agents App 20030225059 - Pineiro, Jose Luis Castro ; et al. | 2003-12-04 |
| Use of NK-1 receptor antagonists for treating major depressive disorders Grant 6,613,765 - Baker , et al. September 2, 2 | 2003-09-02 |
| 2-aryl indole derivative as antagonists of tachykinins Grant 6,518,273 - Chapman , et al. February 11, 2 | 2003-02-11 |
| Azaindole derivatives and their use as therapeutic agents App 20020022624 - Dinnell, Kevin ; et al. | 2002-02-21 |
| 2-aryl indole derivatives and their use as therapeutic agents App 20010039286 - Dinnell, Kevin ; et al. | 2001-11-08 |
| Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents Grant 6,214,846 - Elliott April 10, 2 | 2001-04-10 |
| Spiro-azacyclic derivatives and their use as therapeutic agents Grant 6,172,077 - Curtis , et al. January 9, 2 | 2001-01-09 |
| Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety Grant 6,114,315 - Baker , et al. September 5, 2 | 2000-09-05 |
| Spiro-piperidine derivatives and their use as therapeutic agents Grant 6,071,927 - Baker , et al. June 6, 2 | 2000-06-06 |
| Serine derivatives and their use as therapeutic agents Grant 5,885,999 - Elliott , et al. March 23, 1 | 1999-03-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 